Daily News

A live parasite vaccine for deadly leishmaniasis

A live parasite vaccine for deadly leishmaniasis

A live parasite vaccine for deadly leishmaniasis

A GLP-grade non-replicative Leishmania major parasite protects hamsters from lethal leishmaniasis infection, setting the stage for human clinical trials and the first potential vaccine for leishmaniasis.
E. coli may hold the key to manufacturing hard-to-make drugs

E. coli may hold the key to manufacturing hard-to-make drugs

E. coli may hold the key to manufacturing hard-to-make drugs

Scientists combined engineered E. coli with artificial intelligence to produce effective, high-quality protein and antibody-based drugs at a large scale.
Using CRISPR for Disease Eradication

Using CRISPR for Disease Eradication

Using CRISPR for Disease Eradication

Researchers employ CRISPR technology in a variety of creative ways to control the spread of vector-borne illnesses.
Stem cells jump-start the brain after a stroke

Stem cells jump-start the brain after a stroke

Stem cells jump-start the brain after a stroke

Transplanted astrocyte precursor cells promote healing in mouse brains after white matter strokes.
A new initiative for developing autologous stem cell therapies

A new initiative for developing autologous stem cell therapies

A new initiative for developing autologous stem cell therapies

A biopharmaceutical company established a new method for isolating and editing hematopoietic stem cells from patients to provide stem cell therapies for diseases such as sickle cell disease.
CAR T cell therapy gives glioblastoma patients hope

CAR T cell therapy gives glioblastoma patients hope

CAR T cell therapy gives glioblastoma patients hope

Christine Brown develops CAR T cell therapies that may one day provide a long-sought-after cure for malignant brain cancers.
Subscribe to our eNewsletters

Stay connected with all the latest DDN news!

Latest Issue's Magazine Cover

Latest Issue  

• Volume 17 • Issue 9 • September 2021

September 2021

September 2021 Issue